Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

December 12, 2007 15:28 ET

Meridian to Attend the 15th Annual World Congress on Anti-Aging Medicine

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 12, 2007) - Meridian Medical Inc., the exclusive North American distributors for Meridian Co., Ltd. ("Meridian") (OTCBB:MRDAF) is pleased to announce that it will be attending the 15th Annual International Congress on Anti-Aging Medicine and Biomedical Technology, with an expected attendance of over 5,000 participants seeking innovative treatment modalities.

Joining the Meridian Medical Inc. team, will be the President and CEO of Meridian, Mr. Myeong, and the recently hired International Sales Manager, Scud Kim. "Over the last few years the Anti Aging Conference has always been a successful event for Meridian, and we welcome the opportunity to showcase our products and answer questions that the attendees may have," says Mr. Myeong.

"The anti-aging conferences have always been successful events for Meridian that have increased our sales, distribution channels and presence throughout North America."

This conference is the largest, leading industry event worldwide in the area of preventative medicine and bio-medical technologies. Anti-aging medicine is the fastest growing new medical specialty and Meridian's product line fits perfectly into this progressive environment. In attendance will be some of the most influential physicians, scientists, educators, industrialists, investment bankers and journalists from around the world.

The conference will be held at the Venetian in Las Vegas from December 13 to 15, 2007. Meridian will be demonstrating the LAPEX 2000 LipoLaser, which has recently received Health Canada approval, the Digital Pulse Analyzer, and Bp Tru at booth 3100.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Mexico, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors, Hyeon Seong Myeong President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information